Thirty years after moving to Saudi Arabia for work, 58-year-old Musaddik Abbas Tandel returned home to Raigad hoping for a ...

Real-World LEQEMBI Data Shows Patients Choose to Stay on Long-Term TreatmentTOKYO and CAMBRIDGE, Mass., March 20, 2026 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, ...

Tenax Therapeutics is a "Sell" given its negative risk/reward skew even under bullish scenarios. Here's what investors need to know about TENX stock.

Ad hoc announcement pursuant to Art. 53 LR BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts ...

As of Monday, March 16, NRx Pharmaceuticals, Inc.’s NRXP share price has surged by 13.44%, which has investors questioning if this is right time to sell.

The neuromyelitis optica spectrum disorder market size in the 7MM is expected to show positive growth during the forecast period (2026--2036), mainly attributed to the increasing prevalence of NMOSD, ...

Insulin therapy is central to type 1 diabetes and many cases of type 2. It lowers glucose effectively, yet it also introduces predictable risks. Understanding side effects helps patients plan […] ...

From ham sandwiches to cat-induced injuries, here are some of the excuses for gigs being cancelled.

Fragments Of Loneliness, a new play by Chakorn Chamai, will stage on Friday at LiFE Studio in Bangkok's Phra Nakhon district, inviting audiences to examine an urban malaise in an achievement society.

BioVersys receives US FDA nod to recruit US patients for BV100 HABP/VABP phase 3 trial to treat hospital-acquired or ventilator-associated bacterial pneumonia: Basel, Switzerland ...

Recently published Epidermolysis Bullosa Market Insights report includes a comprehensive understanding of current treatment practices, epidermolysis bullosa emerging drugs, market share of individual ...